Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Venlafaxine for Depressed Cocaine Abusers
NCT00249483Phase 2Completed
- Sponsor
- New York State Psychiatric Institute
- Start
- Oct 1999
- Primary completion
- Feb 2005
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of venlafaxine in cocaine dependence, major depressive disorder (MDD), sponsored by New York State Psychiatric Institute. Started Oct 1999; status: completed.
02
Drugs
venlafaxine
03
Conditions
cocaine dependencemajor depressive disorder (MDD)
Beyond the preview
Go deeper on NCT00249483.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00249483.